0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV-4.17%PremiumOct 18, 2024Expiry Date0.20Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma8.00Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Autolus Therapeutics Stock Discussion
Abeona Therapeutics ( $Abeona Therapeutics (ABEO.US)$ )
Asset: Pz-cel (prademagene zamikeracel)
PDUFA Date: May 25, 2024
Indication: Recessive dystrophic epidermolysis bullosa (RDEB)
Technology: Autologous cell therapy, treatment uses gene transfer to deliver COL7A1 genes into an RDEB patient’s own skin cells then transplanting them back to the patient.
Rocket Pharmaceuticals ( $Rocket Pharmaceuticals (RCKT.US)$ ) ...
Pre-market Magic: Wanna know the insider scoop before the market opens? Our talented crew will give you the lowdown on pre-market movements, giving you a sneak peek into the thrill of investing!
FDA Calendar Know-how: Confused about FDA approval processes? Fear not! Our FDA Calendar will turn you into a pharma whiz, keeping you in the loop with crucial timings!
Money Trail: Curious about where the funds are flowing? The Fundraising Tracker '23 is here to spill the beans, ...
$Autolus Therapeutics (AUTL.US)$
$Bright Minds Biosciences (DRUG.US)$
No comment yet